According to Innoviva's latest financial reports and stock price the company's current number of shares outstanding is 67,786,000. At the end of 2023 the company had 67,786,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 67.78 M | -2.68% |
2022 | 69.65 M | 0.24% |
2021 | 69.49 M | -31.44% |
2020 | 0.10 B | 0.16% |
2019 | 0.10 B | 0.22% |
2018 | 0.10 B | -4.88% |
2017 | 0.10 B | -1.38% |
2016 | 0.10 B | -6.55% |
2015 | 0.11 B | 1.84% |
2014 | 0.11 B | 32.04% |
2013 | 85.65 M | 11.86% |
2012 | 76.57 M | 15.2% |
2011 | 66.47 M | 11.89% |
2010 | 59.4 M | 16.59% |
2009 | 50.95 M | 2.75% |
2008 | 49.59 M | 1.45% |
2007 | 48.88 M | 1.51% |
2006 | 48.15 M | 11.88% |
2005 | 43.04 M | 18.38% |
2004 | 36.36 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | 751,506,257 | 1,008.65% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | 20,960,171 | -69.08% | ๐บ๐ธ USA |